Real-world Prevalence of Nonintegrase INSTI Resistance-Associated Mutations and Virological Outcomes in People Who Have Recently Acquired HIV-1 in the United Kingdom
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf500 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Christine Kelly und 9 weiteren Autor:innen. Beteiligte Einrichtung: Virus Reference Department, UK Health Security Agency, Colindale, United Kingdom. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Mutation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Blood Borne and Sexually Transmitted Infections.
Abstract (Originalsprache)
Background
Integrase strand transfer inhibitors (INSTIs) are the mainstay of antiretroviral therapy (ART) globally. Virological breakthrough is uncommon but often manifests as low-level viremia, and only 50% of cases have identified drug resistance mutations in the integrase gene. Nonintegrase mutations in the Gag-nucleocapsid protein (NC), envelope glycoprotein (Env), and 3′ polypurine tract (3′PPT) have been identified in vitro.
Methods
Between 2015 and 2021, human immunodeficiency virus type 1 (HIV-1) whole genome sequencing was performed on samples from people with recently acquired HIV-1 in the United Kingdom. Sequences were linked to demographic and clinical data within the UK Health Security Agency's HIV and AIDS Reporting System. The relationship between nonintegrase enzyme mutations and virological outcomes was assessed. Of 1106 participants, 375 (34%) started an INSTI-based regimen. Of these, 337 (90%) were men and 196 (52%) were living with subtype B. The median age was 33 years and number of viral loads within 24 months of starting ART was 4.
Results
Overall, Env Y61H (33 [10%]), A539V (16 [5.0%]), 3′PPT c9053t (17 [5.0%]), and NC N8S (16 [4.8%]) were the most prevalent nonintegrase enzyme mutations. Univariable and multivariable Cox regression did not identify significant associations between the presence of these mutations individually and time to viral suppression, or to viral blip. Interestingly, accessory INSTI mutations were found significantly more frequently in people whose virus also harbored the Env mutation A539V (P = .002).
Conclusions
Several nonintegrase mutations were prevalent, but we found no evidence of an impact upon virological outcomes within treatment-naive individuals on INSTI-based regimens who had recently acquired HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virus Reference Department, UK Health Security Agency, Colindale, United Kingdom.
- Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.
- Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency, London, United Kingdom.
- Institute for Global Health, University College London, London, United Kingdom.
- National Institute for Health and Care Research Health Protection Research Unit in Bloodborne and Sexually Transmitted Infections, University College London, London, United Kingdom.
- Department of Medicine of Systems, University of Rome Tor Vergata, Rome, Italy.
ORCID-Profile: Christine Kelly, James S Lester, Daniel Bradshaw, David F Bibby, Gary Murphy, Alison Brown, Caroline Sabin, Anna-Maria Geretti, Jean L Mbisa
Förderung
- Blood Borne and Sexually Transmitted Infections
Zitieren
APA
Kelly, C., Lester, J. S., Bradshaw, D., Bibby, D. F., Mohamed, H., Murphy, G., Brown, A., Sabin, C., Geretti, A. M., & Mbisa, J. L. (2026). Real-world Prevalence of Nonintegrase INSTI Resistance-Associated Mutations and Virological Outcomes in People Who Have Recently Acquired HIV-1 in the United Kingdom. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf500
Vancouver
Kelly C, Lester JS, Bradshaw D, Bibby DF, Mohamed H, Murphy G, et al. Real-world Prevalence of Nonintegrase INSTI Resistance-Associated Mutations and Virological Outcomes in People Who Have Recently Acquired HIV-1 in the United Kingdom. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf500
BibTeX
@article{Kelly2026,
author = {Kelly, Christine and Lester, James S and Bradshaw, Daniel and Bibby, David F and Mohamed, Hodan and Murphy, Gary and Brown, Alison and Sabin, Caroline and Geretti, Anna-Maria and Mbisa, Jean L},
title = {Real-world Prevalence of Nonintegrase INSTI Resistance-Associated Mutations and Virological Outcomes in People Who Have Recently Acquired HIV-1 in the United Kingdom},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf500}
}
EUVIMED